PET/CT can predict therapy response in some lymphomas

Article

PET/CT can predict therapy response in some lymphomas

A Johns Hopkins University study added to the growing base of evidence showing that quantitative PET/CT can predict the response to treatment in patients with bone metastases from lymphomas.

Dr. Behnaz Goudarzi and colleagues retrospectively reviewed PET/CT reports from 1100 patients with lymphoma. They identified a subset of 28 patients with aggressive lymphoma and bone lesions with high FDG uptake and compared standardized uptake values and Hounsfield unit values for these lesions before and after therapy. Evidence of treatment response came in the form of significant decrease in FDG uptake and increase in tumor density. They presented their findings at the 2007 RSNA meeting .

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.